Safety and Efficacy of Intravitreal Ranibizumab as a Preoperative Adjunct Treatment Before Vitrectomy Surgery in Proliferative Diabetic Retinopathy (PDR) Compared to Vitrectomy Alone (VITARM)
This study is ongoing, but not recruiting participants.
Sponsor:
Attila Vajas
Collaborator:
Semmelweis University
Information provided by (Responsible Party):
Attila Vajas, University of Debrecen
ClinicalTrials.gov Identifier:
NCT00931125
First received: July 1, 2009
Last updated: February 7, 2013
Last verified: February 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is ongoing, but not recruiting participants. |
|---|---|
| Estimated Study Completion Date: | November 2013 |
| Estimated Primary Completion Date: | September 2013 (Final data collection date for primary outcome measure) |